MARKET

FWBI

FWBI

First Wave Biopharma Inc
NASDAQ
1.400
-0.260
-15.66%
After Hours: 1.459 +0.059 +4.24% 17:27 06/08 EDT
OPEN
1.750
PREV CLOSE
1.660
HIGH
1.780
LOW
1.277
VOLUME
248.24K
TURNOVER
0
52 WEEK HIGH
79.80
52 WEEK LOW
1.277
MARKET CAP
2.54M
P/E (TTM)
-0.0672
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 5h ago
IDEX, APRN and CAMP among mid-day movers
Seeking Alpha · 6h ago
First Wave Biopharma Inc: General form for registration of securities under the Securities Act of 1933
Press release · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 05/29 13:06
Gamida Cell Appoints Terry Coelho As CFO, Effective Immediately
Benzinga · 05/22 12:05
Expert Ratings for First Wave BioPharma
Benzinga · 05/15 15:01
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Lowers Price Target to $10
Benzinga · 05/15 10:43
First Wave Bio (FWBI) Receives a Buy from H.C. Wainwright
TipRanks · 05/15 10:25
More
About FWBI
First Wave BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal (GI) diseases. It is focused on developing its pipeline of gut-restricted GI clinical drug candidates, including the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, and niclosamide, which is an oral small molecule with anti-viral and anti-inflammatory properties. Its adrulipase programs are focused on the development of an oral, non-systemic, biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis. It is advancing two separate Phase 2 clinical programs of its niclosamide formulations, including FW-COV for Severe Acute Respiratory Syndrome Coronavirus 2 GI infections, and FW-UP for ulcerative proctitis and ulcerative proctosigmoiditis.

Webull offers kinds of First Wave BioPharma Inc stock information, including NASDAQ:FWBI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FWBI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FWBI stock methods without spending real money on the virtual paper trading platform.